Hopman Markinsider trades
In SEC Form 4 filings, Hopman Mark is listed as Chief Commercial Officer of Beta Bionics, Inc. (BBNX). In the last 90 days, Hopman Mark sold $1.42M of Beta Bionics, Inc. (BBNX) on the open market and bought none. 3 of the 6 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BBNXBeta Bionics, Inc. | Chief Commercial Officer | 6 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
Dashed line = amended filing (Form 4/A)
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BBNXBeta Bionics, Inc. | Oct 14 | Oct 16 | S | 775 | $17.35 | Sale −$13,446 | 55,334 | No | Form 4 |
| BBNXBeta Bionics, Inc. | Oct 1 | Oct 5 | S | 370 | $18.96 | Sale −$7,015 | 56,109 | No | Form 4 |
| BBNXBeta Bionics, Inc. | Sep 9 | Sep 184/A | S | 35,994 | $18.46 | Sale −$664,550 | 88,033 | Yes | Form 4/A |
| BBNXBeta Bionics, Inc. | Sep 16 | Sep 17 | S | 30,779 | $20.13 | Sale −$619,640 | 56,479 | Yes | Form 4 |
| BBNXBeta Bionics, Inc. | Sep 14 | Sep 15 | S | 775 | $15.52 | Sale −$12,028 | 86,382 | Yes | Form 4 |
| BBNXBeta Bionics, Inc. | Sep 2 | Sep 3 | S | 5,327 | $19.11 | Sale −$101,815 | 124,027 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.